New research from the University of Bristol and University Hospital Southampton has concluded that eplerenone offers no benefit for patients suffering from central serous chorioretinopathy (CSCR), and subsequently should no longer be prescribed for the condition. Read more
A new smart contact lens design capable of preventing dry eye has the potential to solve a significant problem associated with the emerging technology. Read more
A study examining the eyes of 1,400 Hong Kong children has a drawn a link between secondhand smoke and eye damage.
Australian researchers have identified 107 genes that increase the risk of glaucoma and developed a genetic test to detect people at risk of going blind from the condition. Read more
Australia-based research into bionic eye technology is expanding internationally, with global tests planned after the successful results of a four-patient trial in Melbourne. Read more
South Australian researchers have developed a new method to assess myopia using optical coherence tomography (OCT). Read more
Projects to develop decision support software for macular disease, sustained release ocular implants and a control sleeve for intravitreal injections are a step closer to commercial development, following the latest round of government research grants. Read more
Melbourne biopharmaceutical company Opthea has completed the patient recruitment phase for the latest trial of its novel therapy for diabetic macular edema (DME). Read more
New research has drawn a link between severe sleep apnoea and diabetic macular oedema, firming up the connection between the two conditions.
By combining archaea and mammal DNA, researchers are hoping to ‘bypass evolution’ and give people genes that would allow them to resist retinal degeneration.